Cisplatin-induced AKI risk stratification and safety of dose reduction in urothelial carcinoma patients with renal impairment.
Saved in:
| Title: | Cisplatin-induced AKI risk stratification and safety of dose reduction in urothelial carcinoma patients with renal impairment. |
|---|---|
| Authors: | Yamamoto S; Departamento de Urología, Kimitsu Chuo Byoin, Japan. Electronic address: satoshi.ym0809@gmail.com., Higa K; Departamento de Urología, Kimitsu Chuo Byoin, Japan., Kurokawa K; Departamento de Urología, Kimitsu Chuo Byoin, Japan., Bamba H; Departamento de Urología, Kimitsu Chuo Byoin, Japan., Kanaoka S; Departamento de Urología, Kimitsu Chuo Byoin, Japan., Nakamura K; Departamento de Urología, Kimitsu Chuo Byoin, Japan. |
| Source: | Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2025 Dec; Vol. 49 (10), pp. 501864. Date of Electronic Publication: 2025 Oct 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier España Country of Publication: Spain NLM ID: 101771154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5786 (Electronic) Linking ISSN: 21735786 NLM ISO Abbreviation: Actas Urol Esp (Engl Ed) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2173-5786 |
|---|---|
| DOI: | 10.1016/j.acuroe.2025.501864 |
